Genesco Inc.
NYSE:GCOApparel - Retail
+$1.44 today
- Market cap
- $386.71M
- Beta
- 1.82
- P/E (TTM)
- 19.1
- EPS (TTM)
- $1.89
Volume 0.11M
Average 0.23M
GCO Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Genesco Inc.NYSE: GCO
Capital Expenditures · Q1 FY2027 · quarter ended May 2026
Capital expenditures dips below year-ago levels
Q1 FY2027 capital expenditures of $15.42M (cash outflow) fell 18.4% year over year, behind the +106.5% change in trailing-twelve-month capital expenditures. Over 3 fiscal years it compounded at +1.2% a year.
Context
- Capital expenditures amounted to 2.5% of revenue in FY2026, up 0.8 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
- FY2026 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -18.4% toward the trailing-twelve-month pace of +106.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2026
- (62.05M) USD
- Year-over-year change
- -50.9%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | (62.05M) | -50.9% |
| FY2025 | 2025-02-01 | (41.13M) | +31.8% |
| FY2024 | 2024-02-03 | (60.3M) | -0.6% |
| FY2023 | 2023-01-28 | (59.93M) | -11.2% |
| FY2022 | 2022-01-29 | (53.91M) | — |
Capital Expenditures vs competitors
How GCO compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +106.5% is the 4th highest of 10, against a peer median of +34.6%.
- Capital expenditures amounts to 0.1% of revenue for GCO, versus a peer median of 2.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
EMPDEmpery Digital Inc. | LTM Mar 2026 | $451.66M USD | +118070.1% | -36.5% | 97208.8% |
| LTM Apr 2026 | $74.99M USD | -32.4% | +23.8% | 5.9% | |
| LTM Mar 2026 | $33.91M USD | +155.4% | +36.6% | 5.6% | |
| LTM Apr 2026 | $29.49M USD | +61.1% | +4.4% | 5.9% | |
| LTM May 2026 | $24.06M USD | +126.5% | -3.0% | 2.8% | |
| LTM Mar 2026 | $20.5M USD | -35.6% | -11.5% | 2.7% | |
| LTM Mar 2026 | $17.02M USD | +7.6% | -23.0% | 2.5% | |
| LTM Jan 2026 | $15.38M USD | +34.6% | -27.3% | 0.9% | |
| LTM Mar 2026 | $8.34M USD | -19.4% | -9.2% | 2.8% | |
| LTM May 2026 | $3.48M USD | +106.5% | +1.2% | 0.1% | |
| LTM Dec 2025 | CN¥0 CNY | — | -42.3% | 0.0% | |
| Peer median (excluding GCO) | — | +34.6% | -10.4% | 2.8% | |
Competitors are the stored peer set for GCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Feb 2024 | FY2025 Feb 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 114.85M | 71.92M | (16.83M) | (18.89M) | 13.27M |
| Depreciation & Amortization | 42.97M | 42.82M | 49.44M | 52.46M | 53.33M |
| Deferred Income Tax | (18.71M) | (26.39M) | 3.45M | 26.76M | (1.21M) |
| Stock-Based Compensation | 9.13M | 14.02M | 14.4M | 12.87M | 12.24M |
| Change in Working Capital | 107.82M | (269.61M) | 13.66M | 12.01M | 62.67M |
| Accounts Receivables | (8.28M) | (1.08M) | (13.29M) | 4.3M | 9.8M |
| Inventory | 10.83M | (183.58M) | 80.35M | (49.08M) | (1.16M) |
| Accounts Payables | 3.76M | (11.84M) | (27.67M) | 54.33M | (13.18M) |
| Other Working Capital | 101.51M | (73.11M) | (39.02M) | 2.46M | 67.22M |
| Other Non-Cash Items | (16.19M) | 2.37M | 30.67M | 2.68M | 5.46M |
| Operating Cash Flow | 239.87M | (164.88M) | 94.8M | 87.89M | 145.76M |
| Capital Expenditures | (53.91M) | (59.93M) | (60.3M) | (41.13M) | (62.05M) |
| Acquisitions (Net) | (80K) | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 20.09M | 0 | 302K | 1K | 0 |
| Investing Cash Flow | (33.9M) | (59.93M) | (60M) | (41.13M) | (62.05M) |
| Debt Repayment | (19.03M) | 30.05M | (10.6M) | (34.64M) | 566K |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (78.07M) | (77.47M) | (32.03M) | (9.79M) | (12.57M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (5.87M) | 1.89M | (4.96M) | (2.57M) | (1.32M) |
| Financing Cash Flow | (101.17M) | (45.53M) | (47.58M) | (47M) | (13.32M) |
| Effect of Forex Changes | 631K | (2.19M) | (51K) | (900K) | 1.01M |
| Net Change in Cash | 105.43M | (272.54M) | (12.84M) | (1.15M) | 71.4M |
| Free Cash Flow | 185.97M | (224.82M) | 34.49M | 46.75M | 83.71M |
Genesco Inc.
NYSE:GCO
Intrinsic Alpha fair value
Locked
Current Price
$35.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.